Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
NCT00465959 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2013-12-27
Summary
To assess the effect of a single dose of TrIP on pulmonary function in patients with COPD
Conditions
Interventions
- DRUG
-
trospium chloride inhalation powder (TrIP)
- DRUG
Sponsors & Collaborators
-
Alkermes, Inc.
collaborator INDUSTRY -
Endo Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2007-06-30
- Completion
- 2007-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation
NCT02172508 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants
NCT06091579 ·Status: COMPLETED ·Phase: PHASE1
-
Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
NCT02177318 ·Status: COMPLETED
-
Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma
NCT00152984 ·Status: COMPLETED ·Phase: PHASE4
-
Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
NCT04780984 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment
NCT02172781 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172430 ·Status: COMPLETED ·Phase: PHASE3
-
Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)
NCT06480890 ·Status: COMPLETED
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers
NCT02259959 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes
NCT01691079 ·Status: COMPLETED ·Phase: PHASE4
-
Tiotropium Bromide in Cystic Fibrosis
NCT01179347 ·Status: COMPLETED ·Phase: PHASE3
-
Tiotropium / Respimat One-Year Study
NCT00168831 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease
NCT00106821 ·Status: COMPLETED ·Phase: PHASE4
-
Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting
NCT03627858 ·Status: COMPLETED
-
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD
NCT00240435 ·Status: COMPLETED ·Phase: PHASE3
-
Tiotropium (Spiriva) Rehabilitation Study
NCT00274521 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172300 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients
NCT02172534 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis
NCT00737100 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response
NCT06679465 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00870896 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tiotropium Respimat Administration With and Without Aerochamber Disease (COPD)
NCT04999930 ·Status: COMPLETED ·Phase: NA
-
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
NCT00570544 ·Status: COMPLETED
-
Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT05986591 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00144326 ·Status: COMPLETED ·Phase: PHASE3